News

News
Other news

Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection

Read full story
Other news

CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device

Read full story
Other news

binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Winners of the Victorian QuickFire Challenge in Collaboration with Victorian Government

Read full story
Partner news

Accelerator Life Science Partners Launches Magnolia Neurosciences Corporation with $31 Million Series A to Develop Targeted Neuroprotective Therapies

Read full story
JNJ Press releases

Johnson & Johnson Medical Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge: Robotics & Digital Surgery in Collaboration with Seoul Metropolitan Government and KHIDI

Read full story
In the media

Johnson & Johnson leads the way to a world without disease

Read full story
Partner news

CVRx® Secures $113 Million in New Financing

Read full story
Partner news

Torax Medical, Inc. Raises $25 Million in Series E Funding and Welcomes New Chief Commercial Officer

Read full story
Partner news

Merus Enters into 72.8 million Euro Series C Financing

Read full story
Partner news

Catalyst Biosciences Completes Merger with Targacept and Creates a Protease-Based Hemostasis and Anti-Complement Company

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Collaboration on Immuno-Oncology Antibody ADC-1013 with Alligator Bioscience

Read full story
Partner news

Johnson & Johnson Innovation Announces Collaboration on Immuno-Oncology Antibody ADC-1013 with Alligator Bioscience

Read full story
Partner news

Aquinox Pharmaceuticals Commences Phase II Clinical Trial of AQX-1125 in Bladder Pain Syndrome/Interstitial Cystitis

Read full story
Partner news

Celladon Corporation Announces First Patient Dosed in CUPID Phase 2b Trial of MYDICAR® for Advanced Heart Failure

Read full story